HIV-neutralizing antibodies: epitope identification and significance for future vaccine.

about

Immune escape by human immunodeficiency virus type 1 from neutralizing antibodies: evidence for multiple pathways.

P2860

Q36655438-1D4A2816-B687-499A-932A-B787385DBBD6

P2860

HIV-neutralizing antibodies: epitope identification and significance for future vaccine.

Item

http://www.wikidata.org/entity/Q36708990

description

1990 nî lūn-bûn

@nan

1990年の論文

@ja

1990年論文

@yue

1990年論文

@zh-hant

1990年論文

@zh-hk

1990年論文

@zh-mo

1990年論文

@zh-tw

1990年论文

@wuu

1990年论文

@zh

1990年论文

@zh-cn

name

HIV-neutralizing antibodies: epitope identification and significance for future vaccine.

@ast

HIV-neutralizing antibodies: epitope identification and significance for future vaccine.

@en

type

Item

label

HIV-neutralizing antibodies: epitope identification and significance for future vaccine.

@ast

HIV-neutralizing antibodies: epitope identification and significance for future vaccine.

@en

prefLabel

HIV-neutralizing antibodies: epitope identification and significance for future vaccine.

@ast

HIV-neutralizing antibodies: epitope identification and significance for future vaccine.

@en

P1476

HIV-neutralizing antibodies: epitope identification and significance for future vaccine.

@en

P2093

Robert-Guroff M

http://www.w3.org/2001/XMLSchema#string

P2860

Complete nucleotide sequence of the AIDS virus, HTLV-III

Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor

Functional regions of the envelope glycoprotein of human immunodeficiency virus type 1

A general model for the transmembrane proteins of HIV and other retroviruses.

Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides.

Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120

Human immunodeficiency virus type 1 neutralization epitope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzees.

Presence of antibodies to a putatively immunosuppressive part of human immunodeficiency virus (HIV) envelope glycoprotein gp41 is strongly associated with health among HIV-positive subjects.

Induction of anti-human immunodeficiency virus (HIV) neutralizing antibodies in rabbits immunized with recombinant HIV--hepatitis B surface antigen particles.

Vaccine protection against simian immunodeficiency virus infection.

P304

15-30

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/08830189009061762

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

1990-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

1722498

http://www.w3.org/2001/XMLSchema#string

HIV-neutralizing antibodies: epitope identification and significance for future vaccine.

about

P2860

P2860

HIV-neutralizing antibodies: epitope identification and significance for future vaccine.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698